Updates on COVID-19 (including visitor restrictions and mask requirements), monkeypox and flu. See Communicable Disease Updates

Your browser is out-of-date!

Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.


Scripps Researcher Praises $1,000 Genome Breakthrough


More than a decade after the first human genome was sequenced for hundreds of millions of dollars, San Diego-based Illumina has unveiled its new DNA mapping system that can do the job for $1,000.

Breaking the $1,000 cost barrier is significant because researchers can now afford to sequence the large numbers of people needed to understand the role of DNA in a wide range of diseases and medical conditions, Scripps Health Chief Academic Officer Eric Topol, MD, told the U-T San Diego.

Dr. Topol is a leading genomics scientist who directs the Scripps Translational Science Institute in La Jolla.

Read the U-T San Diego article here: Illumina Breaks Genome Cost Barrier

Media Contact

Keith Darce